UncategorizedNew Releases from NCBI BookshelfVutrisiran for treating hereditary transthyretin-related amyloid.Vutrisiran for treating hereditary transthyretin-related amyloid. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfRemdesivir and tixagevimab plus cilgavimab for treating COVID-19.Remdesivir and tixagevimab plus cilgavimab for treating COVID-19. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfIxazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma.Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfNintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted.Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfRegorafenib for previously treated metastatic colorectal cancer.Regorafenib for previously treated metastatic colorectal cancer. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfPolatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma.Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfAxicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies.Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfNivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma.Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfCannabidiol for treating seizures caused by tuberous sclerosis complex.Cannabidiol for treating seizures caused by tuberous sclerosis complex. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfMitapivat for treating pyruvate kinase deficiency (terminated appraisal).Mitapivat for treating pyruvate kinase deficiency (terminated appraisal). Leave a Comment / Uncategorized / admin Post Content